AGC Biologics starts construction at new Copenhagen facility
CDMO AGC Biologics has announced the groundbreaking of a new multipurpose facility in Copenhagen, Denmark.
CDMO AGC Biologics has announced the groundbreaking of a new multipurpose facility in Copenhagen, Denmark.
The UK health regulator has today given approval for the first monoclonal antibody treatment for the prevention and treatment of COVID-19 in the UK.
AZD7442, a combination of two long-acting antibodies (LAAB), reduced the risk of developing symptomatic COVID-19 by 77%, according to results from a Phase 3 trial.